Search Results 1881-1890 of 13397 for monoclonal antibody

1. Study Of Durvalumab And Tremelimumab As First-line Treatment In Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

   Patients with HCV infection must have confirmed diagnosis of HCV characterized by the presence of detectable HCV RNA or anti-HCV antibody upon enrollment ( ...

2. Blood and Marrow Transplant Research Program - Transplant Research Center - Mayo Clinic Research

   Immunoglobulin light chain (AL) amyloidosis and POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder, and ...

3. A Study Of Nivolumab In Participants With Metastatic Or Unresectable Bladder Cancer - Mayo Clinic

   ... antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways ... Positive test for hepatitis B virus surface antigen (HBV s Ag) or ...

4. Relapsed or High-Risk Myeloma Receiving Novel Immunotherapies Outcomes of Patients - Mayo Clinic

   Participation eligibility · BCMA targeted cellular therapy including chimeric antigen receptor Tcells (CAR T-cells).; · BCMA targeted antibody-drug conjugate ...

5. A Study To Assess The Effectiveness And Safety Of Ublituximab In Combination With Umbralisib And Venetoclax (U2-V) Compared To Ublituximab And Umbralisib (U2) In Subjects With Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   ... antibody) or chronic active Hepatitis C infection (HCV), cytomegalovirus (CMV), or known history of HIV. Subjects with positive HBc antibody or HCV antibody ...

6. A Study To Assess The Safety, Tolerability, And Pharmacokinetics Of BIIB078 In Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis - Mayo Clinic

   ... antibody immunoglobulin G, and positive HBcAb) or vaccination (defined as positive hepatitis B surface antibody) are eligible to participate in the study.

7. Lymphoma - Doctors and departments - Mayo Clinic

   nstrom macroglobulinemia, Monoclonal gammopathy of undetermined significance ... Bispecific antibody therapy · Bone marrow transplant · Cancer treatment ...

8. Multiple myeloma - Doctors and departments - Mayo Clinic

   Vincent Rajkumar, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. Areas of focus: Amyloidosis, Multiple myeloma, Monoclonal gammopathy of undetermined ...

9. A Study Comparing BGB-3111 And Ibrutinib In Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   Participation eligibility · Presence of hepatitis B surface antigen (HBsAg) or anti-hepatitis B core antibody (anti-HBc). · Presence of hepatitis C virus (HCV) ...

10. A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed Or Recurred On A CDK4/6 Inhibitor - Mayo Clinic

    Positive test results for hepatitis B core antibody (HBcAb) or hepatitis C virus (HCV) antibody at screening: Patients who are positive for HCV antibody ...